Epigenetic modifications of immune cells in rheumatoid arthritis

Эпигенетические модификации иммунных клеток при ревматоидном артрите
Xiaoyu Tracy Cai, Yao Yao
2025-09-24

DNA methylationHistone modificationsImmune cell epigeneticsNon-coding RNAsRheumatoid arthritis
BACKGROUND: Rheumatoid arthritis (RA) is a chronic autoimmune disease marked by synovial inflammation, joint destruction, and systemic features. Dysregulated immune cells-particularly T cells, B cells, and macrophages-drive its onset and progression. Epigenetic mechanisms, including DNA methylation, histone modifications, RNA editing, and non-coding RNAs, critically shape immune cell activation, differentiation, and effector functions, perpetuating autoimmunity and chronic inflammation. PURPOSE: Although individual epigenetic changes in RA have been widely studied, an integrated overview connecting these alterations to disease pathogenesis and clinical application is lacking. This review aims to synthesize current knowledge on how epigenetic modifications affect key immune populations in RA, evaluate their potential as biomarkers for diagnosis and prognosis, and discuss future directions for precision epigenetic therapies. DISCUSSION: In RA, T cells show locus-specific hypomethylation and lncRNA-mediated regulation that boost inflammatory cytokine production. Macrophages undergo histone modification changes and altered RNA editing that amplify inflammation. B cells exhibit abnormal DNA methylation and microRNA profiles promoting autoantibody production. Together, these processes form a self-sustaining loop of immune activation. Clinically, epigenetic profiles may aid early detection and patient stratification. Targeting epigenetic enzymes and RNA-based therapies is promising but faces challenges in cell specificity, delivery, and variability. CONCLUSION: Advances in epigenetics could enable personalized RA management. Integrative multi-omics and cell-specific interventions may restore immune balance, control inflammation, and prevent damage. Overcoming barriers to targeted delivery and clinical translation will be key for precision epigenetic therapies in RA.
1
Abnormal DNA methylation and microRNA profiles in B cells promote autoantibody production, reinforcing autoimmune activation.
2
Epigenetic dysregulation in T cells, B cells, and macrophages contributes to rheumatoid arthritis onset and persistent inflammation.
3
Epigenetic profiles may support early diagnosis and patient stratification, while therapeutic translation is limited by cell specificity, delivery, and interpatient variability.
4
Histone-modification changes and altered RNA editing amplify inflammatory activity in rheumatoid arthritis macrophages.
5
T-cell locus-specific hypomethylation and long non-coding RNA regulation enhance inflammatory cytokine production in rheumatoid arthritis.

Immune cells in rheumatoid arthritis, particularly T cells, B cells, and macrophages

Epigenetic modifications regulating immune-cell activation, differentiation, effector functions, autoantibody production, and chronic inflammatory pathogenesis, including their biomarker and therapeutic potential

Publication Details
Publication Date
2025-09-24
Journal
Publisher
ISSN
Cited by
13
Access Type
Author Information
Authors
Xiaoyu Tracy Cai
Yao Yao
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%